PHAT - Phathom a buy at Stifel on new heartburn therapy
2024-05-03 14:31:53 ET
More on Phathom Pharmaceuticals
- Phathom: Undervalued Biotech With Possible GERD Treatment Label Expansion
- Phathom Pharmaceuticals, Inc. (PHAT) Q4 2023 Earnings Call Transcript
- Phathom Pharma, Rhythm, Vaxcyte most likely takeover targets in pharma - analyst
- Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals
- Historical earnings data for Phathom Pharmaceuticals